Mereo BioPharma Group Plc

(NASDAQ) MREO

Current Price$0.32

Market Cap$53.47M

Since IPO (2019)-95%

5 Year-89%

1 Year-80%

1 Month+5%

Mereo BioPharma Group Plc Financials at a Glance

Market Cap

$53.47M

Revenue (TTM)

$500.00K

Net Income (TTM)

-$35.70M

EPS (TTM)

-$0.22

P/E Ratio

-1.49

Dividend

$0.00

Beta (Volatility)

1.47 (Average)

Dividend

$0.00

Beta (Volatility)

1.47 (Average)

Price

$0.32

Volume

704,579.178

Open

$0.33

Price

$0.32

Volume

704,579.178

Open

$0.33

Previous Close

$0.32

Daily Range

$0.32 - $0.33

52-Week Range

$0.20 - $2.37

Estimated Earnings Date

Aug 11, 2026

Dividend

$0.00

Beta (Volatility)

1.47 (Average)

Price

$0.32

Volume

704,579.178

Open

$0.33

Previous Close

$0.32

Daily Range

$0.32 - $0.33

52-Week Range

$0.20 - $2.37

Estimated Earnings Date

Aug 11, 2026

MREO News

2 Growth Stocks That Could Deliver 1,000% Returns

George Budwell, PhDOct 31, 2021

MREO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Mereo BioPharma Group Plc

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Denise Vera Scots-Knight, PhD

Website

www.mereobiopharma.com

Headquarters

London, GL W1G 0QF, GB

MREO Financials

Key Financial Metrics (TTM)

Gross Margin

-105.73%

Operating Margin

-7531.06%

Net Income Margin

-7139.75%

Return on Equity

-81.25%

Return on Capital

-93.04%

Return on Assets

-87.90%

Earnings Yield

-67.11%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$53.47M

Shares Outstanding

159.62M

Volume

704.58K

Avg. Volume

3.44M

Financials (TTM)

Gross Profit

-$528.63K

Operating Income

-$37.66M

EBITDA

-$39.29M

Operating Cash Flow

-$26.95M

Capital Expenditure

-$1.52K

Free Cash Flow

-$26.96M

Cash & ST Invst.

$36.22M

Total Debt

$0.00

Mereo BioPharma Group Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$304.49K

-12.3%

Gross Margin

0.00%

N/A

Market Cap

$53.47M

N/A

Market Cap/Employee

$1.37M

N/A

Employees

N/A

Net Income

-$6.71M

+47.9%

EBITDA

-$8.45M

+32.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$36.22M

-42.0%

Total Debt

$0.00

-100.0%

Accounts Receivable

$1.88M

-21.6%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-87.90%

N/A

Return on Invested Capital

-1.09%

N/A

Free Cash Flow

-$4.31M

+50.1%

Operating Cash Flow

-$4.31M

+48.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IMMPImmutep Limited

IMMPImmutep Limited$0.45+7.52%

ALDXAldeyra The

ALDXAldeyra The$1.93-6.76%

PRQRProQR Therapeutics N.V.

PRQRProQR Therapeutics N.V.$1.70-1.73%

ACIUAC Immune S.A.

ACIUAC Immune S.A.$2.45+2.51%

KYTXKyverna Therapeutics, Inc.

KYTXKyverna Therapeutics, Inc.$7.77-8.43%

LXEOLexeo Therapeutics, Inc. Common Stock

LXEOLexeo Therapeutics, Inc. Common Stock$4.65-3.63%

SLNSilence Therapeutics plc

SLNSilence Therapeutics plc$9.29+2.20%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$11.69-0.06%

SOFISoFi Technologies

SOFISoFi Technologies$18.13-0.03%

PATHUiPath

PATHUiPath$11.85+0.01%

VEEETwin Vee Powercats

VEEETwin Vee Powercats$24.86+4.16%

TAT&T

TAT&T$21.55+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$72.64-0.06%

RIGTransocean

RIGTransocean$5.37+0.03%

Questions About MREO

What is the current price of Mereo BioPharma Group Plc?

Mereo BioPharma Group Plc is trading at $0.32 per share.

What is the 52-week range for Mereo BioPharma Group Plc?

Over the past 52 weeks, Mereo BioPharma Group Plc has traded between $0.20 and $2.37.

How much debt does Mereo BioPharma Group Plc have?

As of the most recent reporting period, Mereo BioPharma Group Plc reported total debt of $0.00.

How much cash does Mereo BioPharma Group Plc have on hand?

Mereo BioPharma Group Plc reported $36.22M in cash and cash equivalents in its most recent financial results.

What is Mereo BioPharma Group Plc’s dividend yield?

Mereo BioPharma Group Plc does not currently have a dividend yield.

Mereo BioPharma Group Plc

Mereo BioPharma Group Plc Financials at a Glance

MREO News

2 Growth Stocks That Could Deliver 1,000% Returns

MREO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Mereo BioPharma Group Plc

MREO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Mereo BioPharma Group Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MREO

What is the current price of Mereo BioPharma Group Plc?

What is the 52-week range for Mereo BioPharma Group Plc?

How much debt does Mereo BioPharma Group Plc have?

How much cash does Mereo BioPharma Group Plc have on hand?

What is Mereo BioPharma Group Plc’s dividend yield?

Premium Investing Services